HOME >> MEDICINE >> NEWS
Brain tumor treatment can vary greatly, according to new JAMA study

Primary malignant brain tumors are not very common about 9,000 patients diagnosed per year and are associated with a poor prognosis. Treatment of these patients varies greatly among academic and community centers and can be in conflict with accepted guidelines of care, according to a new study.

Findings are reported in the February 3 issue of The Journal of the American Medical Association (JAMA) in an article titled "Malignant Glioma Patterns of Care."

UCSF Medical Center neuro-oncologist Susan Chang, MD, lead author, says the information gathered from this study will be of substantial benefit to both patients and physicians. The study surveyed close to 800 patients over a two-and-a-half-year period at 52 clinical sites throughout the United States and Canada.

"Our goal in neuro-oncology is to improve the duration and quality of survival of our patients," Chang says. "Providing up-to-date information on the treatment of these patients is very important and a major challenge. Specialists in the neuro-oncology field communicate well with each other, but we need to partner with other healthcare providers, including emergency physicians, primary physicians, neurologists and oncologists in the community, so that the optimum care is provided."

The researchers found that the use of some diagnostic tools and treatment such as magnetic resonance imaging (MRI), radiation and surgery were consistent. But the study also found that fewer than 70 percent of patients who participated in the survey received chemotherapy, despite research findings that it is a useful therapy for brain tumors.

Other findings also raised concerns, according to Chang. Eighty-nine percent of brain-tumor patients received anti-convulsant medication, yet only 31 percent presented with seizures.

"While it is accepted that patients who present with seizures should receive anti-epileptic drugs (AED), there is strong evidence that prophylactic AED have li
'"/>

Contact: Carol Hyman
chyman@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-Feb-2005


Page: 1 2 3 4

Related medicine news :

1. Brain activity prior to treatment flags vulnerability to antidepressant side effects
2. Brain imaging study may hold clues to onset of schizophrenia in people at high risk
3. Brain imaging reveals secrets of love, fear and betrayal
4. Brain imaging studies investigate pain reduction by hypnosis
5. Brain tumor with dismal prognosis in infants can be cured in older children
6. Brain-scanning technologies need standards, according to Stanford researcher
7. Brain activity of men and women during hostile or impulsive acts differs less on nicotine
8. Brain synapse formation linked to proteins, Stanford study finds
9. Brain region identified that controls collecting behavior
10. Brain imaging reveals new language circuits
11. Brain can be trained to process sound in alternate way, study shows

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brain tumor treatment can vary greatly according new JAMA study

(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... creative, breakthrough marketing campaign called 'We Love Smokers' from ... cravings for tobacco. , "It’s important to establish ... be true to it. Our idea, 'We Love Smokers' ... leadership point of view. We created a bold tone ...
(Date:3/4/2015)... 2015 Starting February 2015, Dr. Joseph ... procedures at their new location in Surrey. , In ... and Dr. Gabriel Chu also provide comprehensive ophthalmology services, ... named Fraser Valley Cataract and Laser (FVCL). This state ... College of Physicians and Surgeons of British Columbia. Fraser ...
(Date:3/4/2015)... 2015 " Optrix by Body Glove ... monthly Tech Report, which takes a look at the ... consumers. Scott Steinberg, a special reporter for NewsWatch and ... with viewers how they have an ultra-rugged, waterproof case ... is a major player at the Consumer Electronics Show ...
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
(Date:3/4/2015)... 4, 2015  Bayer HealthCare today announced that ... accepted the company,s Biologics License Application (BLA) for ... is seeking FDA approval of the investigational compound, ... hemophilia A in children and adults. ... therapies to hemophilia A patients who need them," ...
(Date:3/4/2015)... Colo. , March 4, 2015  Heska Corporation ... What:Heska Corporation Invites You to Join Its Fourth Quarter ... WebWhen:Thursday, March 5, 2015 @ 9:00 a.m. (MST) / ... and Year End 2014 Earnings Call link on the ... Simply log on to the web at the address ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4f69k2/negative_pressure ) ... Pressure Wound Therapy Market (Conventional and Single Use ... Growth, Trends and Forecast 2014 - 2020" ... The global negative pressure wound therapy market is ... product types the NPWT market is segmented into ...
Breaking Medicine Technology:FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2
Cached News: